BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9661014)

  • 1. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier.
    Miyama T; Takanaga H; Matsuo H; Yamano K; Yamamoto K; Iga T; Naito M; Tsuruo T; Ishizuka H; Kawahara Y; Sawada Y
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1738-44. PubMed ID: 9661014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
    Yamano K; Yamamoto K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1999 Mar; 27(3):395-402. PubMed ID: 10064572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier.
    Wu JQ; Shao K; Wang X; Wang RY; Cao YH; Yu YQ; Lou JN; Chen YQ; Zhao HZ; Zhang QQ; Weng XH; Jiang C; Zhu LP
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4464-9. PubMed ID: 24867970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J; Yamamoto C; Miyama T; Takanaga H; Matsuo H; Ishizuka H; Kawahara Y; Kuwano M; Naito M; Tsuruo T; Sawada Y
    Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
    Cisternino S; Rousselle C; Debray M; Scherrmann JM
    Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.
    Cisternino S; Rousselle C; Dagenais C; Scherrmann JM
    Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine.
    Ni L; Yu X; Yu Q; Chen X; Jia L
    Drug Metab Lett; 2008 Aug; 2(3):163-8. PubMed ID: 19356088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative proton-coupled organic cation antiporter is involved in uptake of triptans into human brain capillary endothelial cells.
    Svane N; Pedersen ABV; Rodenberg A; Ozgür B; Saaby L; Bundgaard C; Kristensen M; Tfelt-Hansen P; Brodin B
    Fluids Barriers CNS; 2024 May; 21(1):39. PubMed ID: 38711118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.
    DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO
    Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
    Sane R; Agarwal S; Mittapalli RK; Elmquist WF
    J Pharmacol Exp Ther; 2013 Apr; 345(1):111-24. PubMed ID: 23397054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition.
    Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
    J Vet Pharmacol Ther; 2007 Jun; 30(3):242-8. PubMed ID: 17472656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of itraconazole in rats.
    Quinney SK; Galinsky RE; Jiyamapa-Serna VA; Chen Y; Hamman MA; Hall SD; Kimura RE
    Drug Metab Dispos; 2008 Jun; 36(6):1097-101. PubMed ID: 18339815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine.
    Drion N; Lemaire M; Lefauconnier JM; Scherrmann JM
    J Neurochem; 1996 Oct; 67(4):1688-93. PubMed ID: 8858954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
    Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
    Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.
    Cisternino S; Rousselle C; Debray M; Scherrmann JM
    Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.